Pharmacology of Opioid Analgesics

Introduction/Overview Opioid analgesics constitute a cornerstone class of medications for the management of moderate to severe pain. Their therapeutic application spans acute postoperative pain, cancer-related pain, and certain chronic non-cancer pain states, though their use in the latter context remains a subject of considerable debate due to risks of tolerance, dependence, and misuse. The clinical … Read more

Pharmacology of Opioid Analgesics

Introduction/Overview Opioid analgesics constitute a cornerstone class of medications for the management of moderate to severe pain. Their therapeutic application spans acute postoperative settings, traumatic injury, cancer-related pain, and certain chronic non-cancer pain conditions, though their use in the latter context remains a subject of considerable clinical debate. The profound efficacy of these agents is … Read more

Pharmacology of Mood Stabilizers

mood stabilizers

Introduction/Overview The pharmacological management of bipolar spectrum disorders represents a cornerstone of modern neuropsychiatric therapeutics. Mood stabilizers constitute a heterogeneous class of psychotropic agents primarily employed to treat and prevent episodes of mania, hypomania, and depression in bipolar disorder. Their clinical application extends beyond this core indication to include adjunctive treatment in major depressive disorder, … Read more

Pharmacology of Antidepressants

Antidepressant Drugs or antidepressants

Introduction/Overview Major depressive disorder represents a significant global health burden, characterized by persistent low mood, anhedonia, and a constellation of cognitive and somatic symptoms. The pharmacological management of this condition, along with other mood and anxiety disorders, relies primarily on antidepressant medications. These agents modulate central nervous system neurotransmission, primarily targeting monoamine pathways, to alleviate … Read more

Pharmacology of Antipsychotic Drugs

antipsychotics

1. Introduction/Overview Antipsychotic drugs, also termed neuroleptics, constitute a cornerstone class of psychotropic medications primarily employed in the management of psychotic disorders. Their introduction in the mid-20th century with chlorpromazine revolutionized psychiatric care, enabling deinstitutionalization and providing a biological foundation for understanding severe mental illness. The clinical relevance of these agents extends beyond their primary … Read more

Pharmacology of Barbiturates

Introduction/Overview Barbiturates represent a historic class of central nervous system depressant drugs whose clinical use has been largely supplanted by safer alternatives, yet whose pharmacological principles remain foundational to neuropharmacology. Derived from barbituric acid, these agents were once the cornerstone of sedative, hypnotic, and anticonvulsant therapy throughout much of the 20th century. Their profound depressant … Read more

Pharmacology of Barbiturates

Introduction/Overview Barbiturates represent a historic class of central nervous system (CNS) depressant drugs, first introduced into clinical practice in the early 20th century. These agents were once the cornerstone of therapy for conditions such as anxiety, insomnia, and seizure disorders. Their clinical use has diminished significantly with the advent of safer alternatives, most notably the … Read more

Pharmacology of Benzodiazepines

benzodiazepines

Introduction/Overview Benzodiazepines constitute a major class of psychoactive drugs characterized by their sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties. Since the introduction of chlordiazepoxide in 1960, these agents have become fundamental tools in the management of various neurological and psychiatric conditions. Their clinical relevance stems from a rapid onset of action and a generally … Read more

Pharmacology of Sedative-Hypnotics

1. Introduction/Overview Sedative-hypnotic agents constitute a critical class of psychoactive drugs primarily employed to induce sedation, reduce anxiety, and promote sleep. These compounds exert a dose-dependent continuum of central nervous system depression, ranging from mild anxiolysis and sedation at lower doses to hypnosis, general anesthesia, and potentially coma or fatal respiratory depression at higher doses. … Read more

Pharmacology of Drugs for Myasthenia Gravis

Introduction/Overview Myasthenia gravis represents a prototypical autoimmune disorder of the neuromuscular junction, characterized by fatigable weakness of skeletal muscles. The fundamental pathophysiology involves autoantibodies directed against postsynaptic nicotinic acetylcholine receptors, or less commonly against other key proteins such as muscle-specific kinase or lipoprotein-related protein 4. This immunologic attack reduces the number of functional receptors, impairs … Read more